دورية أكاديمية

Comparative diet-gut microbiome analysis in Crohn's disease and Hidradenitis suppurativa.

التفاصيل البيبلوغرافية
العنوان: Comparative diet-gut microbiome analysis in Crohn's disease and Hidradenitis suppurativa.
المؤلفون: Cronin, Peter, McCarthy, Siobhan, Hurley, Cian, Ghosh, Tarini Shankar, Cooney, Jakki C., Tobin, Ann-Marie, Murphy, Michelle, O'Connor, Eibhlís M., Shanahan, Fergus, O'Toole, Paul W.
المصدر: Frontiers in Microbiology; 2023, p1-19, 19p
مصطلحات موضوعية: CROHN'S disease, HIDRADENITIS suppurativa, WESTERN diet, GUT microbiome
مستخلص: Introduction: The chronic inflammatory skin disease Hidradenitis suppurativa (HS) is strongly associated with Crohn's Disease (CD). HS and CD share clinical similarities and similar inflammatory pathways are upregulated in both conditions. Increased prevalence of inflammatory disease in industrialised nations has been linked to the Western diet. However, gut microbiota composition and diet interaction have not been compared in HS and CD. Methods: Here we compared the fecal microbiota (16S rRNA gene amplicon sequencing) and habitual diet of previously reported subjects with HS (n = 55), patients with CD (n = 102) and controls (n = 95). Results and discussion: Patients with HS consumed a Western diet similar to patients with CD. Meanwhile, habitual diet in HS and CD was significantly different to controls. Previously, we detected differences in microbiota composition among patients with HS from that of controls. We now show that 40% of patients with HS had a microbiota configuration similar to that of CD, characterised by the enrichment of pathogenic genera (Enterococcus, Veillonella and Escherichia_ Shigella) and the depletion of putatively beneficial genera (Faecalibacterium). The remaining 60% of patients with HS harboured a normal microbiota similar to that of controls. Antibiotics, which are commonly used to treat HS, were identified as a co-varying with differences in microbiota composition. We examined the levels of several inflammatory markers highlighting that growth-arrest specific 6 (Gas6), which has anti-inflammatory potential, were significantly lower in the 40% of patients with HS who had a CD microbiota configuration. Levels of the proinflammatory cytokine IL-12, which is a modulator of intestinal inflammation in CD, were negatively correlated with the abundance of health-associated genera in patients with HS. In conclusion, the fecal microbiota may help identify patients with HS who are at greater risk for development of CD. [ABSTRACT FROM AUTHOR]
Copyright of Frontiers in Microbiology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:1664302X
DOI:10.3389/fmicb.2023.1289374